ZA200708493B - Crystal form of asenapine maleate - Google Patents

Crystal form of asenapine maleate

Info

Publication number
ZA200708493B
ZA200708493B ZA200708493A ZA200708493A ZA200708493B ZA 200708493 B ZA200708493 B ZA 200708493B ZA 200708493 A ZA200708493 A ZA 200708493A ZA 200708493 A ZA200708493 A ZA 200708493A ZA 200708493 B ZA200708493 B ZA 200708493B
Authority
ZA
South Africa
Prior art keywords
crystal form
asenapine maleate
asenapine
maleate
crystal
Prior art date
Application number
ZA200708493A
Other languages
English (en)
Inventor
Heeres Gerhardus Johannes
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of ZA200708493B publication Critical patent/ZA200708493B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/14—[b,f]-condensed

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA200708493A 2005-04-07 2007-10-04 Crystal form of asenapine maleate ZA200708493B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05102742 2005-04-07

Publications (1)

Publication Number Publication Date
ZA200708493B true ZA200708493B (en) 2009-09-30

Family

ID=35511130

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200708493A ZA200708493B (en) 2005-04-07 2007-10-04 Crystal form of asenapine maleate
ZA200708490A ZA200708490B (en) 2005-04-07 2007-10-04 Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a, 12b-tetrahydro-1H-dibenz[2,3:6,7] oxepino[4,5-c]pyrrole

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200708490A ZA200708490B (en) 2005-04-07 2007-10-04 Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a, 12b-tetrahydro-1H-dibenz[2,3:6,7] oxepino[4,5-c]pyrrole

Country Status (28)

Country Link
EP (2) EP2154134B1 (da)
JP (1) JP2008534657A (da)
KR (1) KR20070116973A (da)
CN (2) CN101175741B (da)
AR (1) AR063188A1 (da)
AT (1) ATE447564T1 (da)
AU (1) AU2006231281B2 (da)
BR (1) BRPI0610677A2 (da)
CA (1) CA2603181A1 (da)
CY (1) CY1109722T1 (da)
DE (1) DE602006010132D1 (da)
DK (1) DK1710241T3 (da)
ES (1) ES2333980T3 (da)
HK (1) HK1094800A1 (da)
HR (1) HRP20100031T1 (da)
IL (1) IL186354A0 (da)
MX (1) MX2007012446A (da)
NO (1) NO20075152L (da)
NZ (1) NZ562125A (da)
PL (1) PL1710241T3 (da)
PT (1) PT1710241E (da)
RS (1) RS51341B (da)
RU (1) RU2397164C2 (da)
SI (1) SI1710241T1 (da)
TW (1) TW200716589A (da)
UA (2) UA93043C2 (da)
WO (1) WO2006106136A1 (da)
ZA (2) ZA200708493B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5027477B2 (ja) * 2005-10-21 2012-09-19 住友化学株式会社 ジベンゾオキセピノピロール化合物およびその中間体の製造方法ならびに新規中間体
TW200817414A (en) * 2006-07-05 2008-04-16 Organon Nv Process for the preparation of asenapine and intermediate products used in said process
CN101563312A (zh) * 2006-12-22 2009-10-21 住友化学株式会社 阿塞那平合成中间体的制备方法
US7875729B2 (en) 2007-01-05 2011-01-25 Synthon Bv Process for making asenapine
JP5245428B2 (ja) 2007-07-06 2013-07-24 住友化学株式会社 トランス−ジベンゾオキセノピロール化合物の製造方法およびその中間体
US7964739B2 (en) 2008-01-04 2011-06-21 N.V. Organon Process for the preparation of asenapine and intermediate products used in said process
EP2453870A2 (en) 2009-06-24 2012-05-23 MSD Oss B.V. Injectable formulations containing asenapine and method of treatment using same
CN101851242B (zh) * 2010-05-25 2013-07-24 上海皓元生物医药科技有限公司 阿塞那平中间体的制备方法
CA2805542C (en) 2010-07-29 2017-12-12 Laboratorios Lesvi, S.L. Novel process for the preparation of asenapine
WO2012038975A2 (en) * 2010-09-22 2012-03-29 Msn Laboratories Limited Process for the preparation of (3ars,12brs)-5-chloro-2-methyl-2,3,3a12b-tetrahydro-1hdibenzo[2,3:6,7] oxepino [4,5-c]pyrrole maleate and it's pharmaceutical composition thereof
ES2575544T3 (es) 2010-12-24 2016-06-29 Medichem, S.A. Procedimientos para la preparación de 5-cloro-2-metil-2,3,3a,12b-tetrahidro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pirrol
ITMI20110734A1 (it) * 2011-05-02 2012-11-03 Olon Spa Sali cristallini di asenapina
WO2013024492A2 (en) * 2011-07-01 2013-02-21 Megafine Pharma (P) Ltd. A process for the preparation of asenapine and novel salts thereof
CN102952144A (zh) * 2011-08-29 2013-03-06 上海华拓医药科技发展股份有限公司 阿森纳平马来酸盐的晶型、制备方法及其药物组合物
US20140336391A1 (en) * 2011-11-28 2014-11-13 Ranbaxy Laboratories Limited Process for the preparation of asenapine intermediate
CN102746209A (zh) * 2012-06-20 2012-10-24 盛世泰科生物医药技术(苏州)有限公司 一种3-（2-（4-氯苯氧基）苯基）-1-甲基-2,4-二酮的合成方法
CN103965206A (zh) * 2013-01-29 2014-08-06 北京京卫燕康药物研究所有限公司 一种阿色纳品马来酸盐的新晶型及制备方法
CN103113379A (zh) * 2013-03-12 2013-05-22 盛世泰科生物医药技术(苏州)有限公司 阿塞那平马来酸盐的合成工艺
CN103254202A (zh) * 2013-05-19 2013-08-21 甘肃皓天化学科技有限公司 阿塞纳平的制备方法
CN103342707B (zh) * 2013-06-28 2015-09-02 甘肃皓天化学科技有限公司 用于制备阿塞纳平中间体的制备方法
CN104447771A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 一种稳定的马来酸阿塞那平化合物
CN103864802B (zh) * 2014-03-31 2016-08-17 四川科伦药业股份有限公司 马来酸阿塞那平的制备方法
CN105693735A (zh) * 2016-01-15 2016-06-22 万特制药(海南)有限公司 马来酸阿塞那平一种制备方法
MX2019007389A (es) 2016-12-20 2019-08-16 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno.
US20180193283A1 (en) 2016-12-20 2018-07-12 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
JP2020525545A (ja) 2017-06-26 2020-08-27 エルテーエス ローマン テラピー−ジステーメ アーゲー アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム
CN109200025A (zh) * 2017-06-29 2019-01-15 哈尔滨莱博通药业有限公司 一种阿森纳平马来酸盐舌下片
CA3101420A1 (en) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
CN110183457A (zh) * 2019-06-27 2019-08-30 浙江天顺药业有限公司 一种阿塞那平及其制备方法
CN112194665A (zh) * 2020-10-20 2021-01-08 连云港杰瑞药业有限公司 一种合成阿塞那平中间体的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.
RU2139051C1 (ru) 1994-03-02 1999-10-10 Акцо Нобель Н.В. Сублингвальная или трансбуккальная фармацевтическая композиция
WO1999032108A1 (en) 1997-12-19 1999-07-01 Akzo Nobel N.V. Org-5222 in the treatment of depression

Also Published As

Publication number Publication date
AU2006231281A1 (en) 2006-10-12
CN101175741B (zh) 2011-06-22
TW200716589A (en) 2007-05-01
BRPI0610677A2 (pt) 2012-10-30
SI1710241T1 (sl) 2010-02-26
PL1710241T3 (pl) 2010-04-30
CN1861604B (zh) 2011-08-31
AU2006231281B2 (en) 2011-04-28
EP2154134A1 (en) 2010-02-17
CA2603181A1 (en) 2006-10-12
HRP20100031T1 (hr) 2010-02-28
JP2008534657A (ja) 2008-08-28
EP2154134B1 (en) 2012-10-24
CY1109722T1 (el) 2014-04-09
PT1710241E (pt) 2009-12-10
EP1710241B1 (en) 2009-11-04
NZ562125A (en) 2010-08-27
MX2007012446A (es) 2007-11-07
ES2333980T3 (es) 2010-03-03
HK1094800A1 (en) 2007-04-13
DE602006010132D1 (de) 2009-12-17
RS51341B (en) 2011-02-28
CN1861604A (zh) 2006-11-15
ZA200708490B (en) 2008-10-29
RU2397164C2 (ru) 2010-08-20
WO2006106136A1 (en) 2006-10-12
UA93043C2 (ru) 2011-01-10
AR063188A1 (es) 2009-01-14
ATE447564T1 (de) 2009-11-15
EP1710241A1 (en) 2006-10-11
DK1710241T3 (da) 2010-03-01
RU2007141161A (ru) 2009-05-20
CN101175741A (zh) 2008-05-07
IL186354A0 (en) 2008-01-20
NO20075152L (no) 2007-11-01
KR20070116973A (ko) 2007-12-11
UA93044C2 (en) 2011-01-10

Similar Documents

Publication Publication Date Title
ZA200708493B (en) Crystal form of asenapine maleate
IL186355A0 (en) Crystal form of asenapine maleate
HK1121497A1 (en) Production of tnfr-fc tnfr-fc
HK1083341A1 (en) Stable crystal of 4-oxoquinoline compound
IL181587A0 (en) Production of ??-abeta
EG26462A (en) Polypeptide production
PL1802579T3 (pl) Pochodne 3-aryloaminopirydynowe
PT1778618E (pt) Síntese de trietilenotetraminas
PL1737304T3 (pl) Zagęszczona płynna formuła
WO2007038678A8 (en) Analogs of ghrelin
IL185757A0 (en) Methods of decreasing calcifcation
EP1799875A4 (en) FERRO-ALLOY PRODUCTION
EP1711484A4 (en) SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES
SI1812422T1 (sl) Kristalna oblika irbesartana
IL178184A0 (en) Synthesis of pyrrole-2-carbonitriles
GB0410498D0 (en) Crystal
ZA200702731B (en) Production of ferro-alloys
SI1814858T1 (sl) Nove kristalne oblike nelfinavir mesilata
IL187326A0 (en) Crystalline form of benzazepinium maleate derivative
ZA200508325B (en) Manufacture of kerbstones
GB0425914D0 (en) Improvements relating to foundations
GB0508526D0 (en) Crystal structure
GB0508123D0 (en) Crystal structure
AU2004906453A0 (en) Production of ferro-allays
AU2005900755A0 (en) Improvements relating to pendulum packers